| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Biofrontera AG (NASDAQ: BFRA)
BFRA Technical Analysis
5
| As on 5th May 2022 BFRA STOCK Price closed @ 2.05 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 6.40 & Strong Sell for SHORT-TERM with Stoploss of 7.44 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BFRASTOCK Price
| Open | 2.04 | Change | Price | % |
| High | 2.11 | 1 Day | 0.21 | 11.41 |
| Low | 1.90 | 1 Week | -0.17 | -7.66 |
| Close | 2.05 | 1 Month | -0.68 | -24.91 |
| Volume | 4530 | 1 Year | -5.00 | -70.92 |
| 52 Week High 8.63 | 52 Week Low 2.03 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| BFRA Daily Charts |
BFRA Intraday Charts |
Whats New @ Bazaartrend |
BFRA Free Analysis |
|
|
BFRA Important Levels Intraday
| RESISTANCE | 2.45 |
| RESISTANCE | 2.32 |
| RESISTANCE | 2.24 |
| RESISTANCE | 2.16 |
| SUPPORT | 1.94 |
| SUPPORT | 1.86 |
| SUPPORT | 1.78 |
| SUPPORT | 1.65 |
BFRA Forecast May 2024
| 4th UP Forecast | 8.16 |
| 3rd UP Forecast | 6.2 |
| 2nd UP Forecast | 4.99 |
| 1st UP Forecast | 3.78 |
| 1st DOWN Forecast | 0.32 |
| 2nd DOWN Forecast | -0.89 |
| 3rd DOWN Forecast | -2.1 |
| 4th DOWN Forecast | -4.06 |
BFRA Weekly Forecast
| 4th UP Forecast | 2.97 |
| 3rd UP Forecast | 2.68 |
| 2nd UP Forecast | 2.49 |
| 1st UP Forecast | 2.31 |
| 1st DOWN Forecast | 1.79 |
| 2nd DOWN Forecast | 1.61 |
| 3rd DOWN Forecast | 1.42 |
| 4th DOWN Forecast | 1.13 |
BFRA Forecast2024
| 4th UP Forecast | 18.18 |
| 3rd UP Forecast | 13.01 |
| 2nd UP Forecast | 9.81 |
| 1st UP Forecast | 6.61 |
| 1st DOWN Forecast | -2.51 |
| 2nd DOWN Forecast | -5.71 |
| 3rd DOWN Forecast | -8.91 |
| 4th DOWN Forecast | -14.08 |
Biofrontera AG ( NASDAQ USA Symbol : BFRA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BFRA Business Profile
Biofrontera AG, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to sunlight that results in sun damage to the skin. Its principal product is Ameluz, a prescription drug for the treatment of lesion-directed and field-directed actinic keratosis. The company also offers BF-RhodoLED lamp, a photodynamic therapy for lesion-directed and field-directed treatment of actinic keratosis; and Belixos, an over-the-counter line of skin care cosmetic products. In addition, it is developing Ameluz for the treatment of field cancerization and nodular basal cell carcinoma. Further, the company's product portfolio includes Xepi, a prescription antibiotic cream for the treatment of impetigo; and Aktipak, a generic drug for the treatment of acne. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany. Address: Hemmelrather Weg 201, Leverkusen, Germany, 51377
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service